Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame
批准号:
10202626
负责人:
Mayland F Chang
金额:
$28.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2022-06-30
中文摘要
摘要
圣母大学的化学-生物化学-生物学接口(CBBI)项目是一个
建立了NIH资助的计划,在多学科环境中培养研究生,
他们在化学和生物学相关学科的界面上接受了重要的培训。CBBI的目标
计划是生产博士科学家谁在学生的核心学科,跨学科的深入培训
培训,以有效地在接口工作,并加强跨学科的沟通技能。CBBI
该计划已经非常成功,并建立了一个优秀的培训环境,为我们的博士前
实习生自2007年以来,我们培养了55名学生,其中33人完成了博士学位,平均
5.19其中包括8名代表性不足的少数民族(URM),其中6人已经获得博士学位。
我们的55名学员有207种出版物,其中94种是第一作者出版物。共3.76篇文章
每名受训人员发表1.71篇第一作者出版物。8个统一报告机制编制了37份出版物,其中
17篇为第一作者出版物;这意味着每个URM有4.63篇出版物,每个URM有2.13篇第一作者出版物。
URM。在过去的9年里,我们的流失率一直非常低,55名学员中只有3名(5.5%)
没有完成博士学位。在过去的5年里,没有一个实习生没有获得博士学位就离开了这个项目。
年,当前培训计划的周期。CBBI计划的特点包括:
高素质的候选人,合作和多学科研究的良好记录,
多样化和强大的一组经验丰富,生产力,和联邦资助的调查人员,可作为
研究导师,导师实验室外的扩展跨学科研究实习,培训
作为补充,还举办多学科研讨会、学员会议、年度专题讨论会,
有效的计划管理,持续评估和改进培训的机制
计划,专业发展和职业安置,优秀的研究设施,以及强大的机构
承诺.我们建议继续培养博士科学家的技能和专业知识,以解决具有挑战性的
生物医学问题,无论学科。圣母大学对此热情支持
培训计划,并将继续提供一个慷慨的奖学金匹配CBBI计划和额外的
资源,包括所有学员的研究实习的费用,由美国国立卫生研究院的资金更新。
英文摘要
Abstract
The Chemistry-Biochemistry-Biology Interface (CBBI) Program at the University of Notre Dame is an
established NIH-funded program, which trains graduate students in a multidisciplinary environment that provides
them with significant training at the interface of chemistry and biology-related disciplines. The goal of the CBBI
Program is to produce PhD scientists who have in-depth training in the student's core discipline, cross-discipline
training to work effectively at the interface, and enhanced interdisciplinary communication skills. The CBBI
Program has been very successful and has established an outstanding training environment for our predoctoral
trainees. Since 2007 we have trained 55 students, 33 of whom have completed PhD degrees in an average of
5.19 years, including 8 underrepresented minorities (URMs), 6 of whom have already received PhD degrees.
Our 55 trainees have 207 publications, of which 94 are first-author publications. This represents 3.76 publications
per trainee and 1.71 first-author publications per trainee. The 8 URMs have produced 37 publications, of which
17 are first-author publications; this represents 4.63 publications per URM and 2.13 first-author publications per
URM. During the past 9 years, our attrition rate has been extremely low, with only 3 of 55 trainees (5.5%) who
did not complete a PhD degree. Not a single trainee has left the program without a PhD degree in the past 5
years, the current cycle of the training program. The characteristics of the CBBI Program include: a large
applicant pool of highly qualified candidates, a strong record of collaborative and multidisciplinary research, a
diverse and strong group of experienced, productive, and federally-funded investigators available to serve as
research mentors, an extended cross-disciplinary research internship outside the mentor's laboratory, training
supplementation with multidisciplinary seminars, trainee meetings, an annual symposium, experienced and
effective program administration, mechanisms for continuous evaluation and improvement of the training
program, professional development and career placement, excellent research facilities, and strong institutional
commitment. We propose to continue to train PhD scientists with the skills and expertise to solve challenging
biomedical problems, regardless of discipline. The University of Notre Dame enthusiastically supports this
training program, and will continue to provide a generous fellowship match to the CBBI Program and additional
resources, including the cost of the research internship for all trainees, upon renewal of funding by the NIH.
期刊论文(235)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.
锌(II)-二吡啶胺配位络合物作为重大利什曼原虫的靶向剂和化疗剂。
DOI:
10.1128/aac.00410-16
发表时间:
2016
期刊:
Antimicrobial agents and chemotherapy
影响因子:
4.9
作者:
[Rice,DouglasR, Vacchina,Paola, Norris-Mullins,Brianna, Morales,MiguelA, Smith,BradleyD]
通讯作者:
Smith,BradleyD
Iron(III)-templated macrolactonization of trihydroxamate siderophores.
三异羟肟酸铁载体的铁(III)模板化大内酯化。
DOI:
10.1021/ol301869x
发表时间:
2012
期刊:
Organic letters
影响因子:
5.2
作者:
[Wencewicz,TimothyA, Oliver,AllenG, Miller,MarvinJ]
通讯作者:
Miller,MarvinJ
Using MTBindingSim as a tool for experimental planning and interpretation.
使用 MTBindingSim 作为实验规划和解释的工具。
DOI:
10.1016/b978-0-12-407757-7.00023-2
发表时间:
2013
期刊:
Methods in cell biology
影响因子:
--
作者:
[Philip,JuliaT, Duan,ArandaR, Alberico,EmilyO, Goodson,HollyV]
通讯作者:
Goodson,HollyV
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
DOI:
10.1158/2767-9764.crc-23-0327
发表时间:
2024-01-31
期刊:
Cancer research communications
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.1002/jmr.896
发表时间:
2008-07
期刊:
JOURNAL OF MOLECULAR RECOGNITION
影响因子:
2.7
作者:
[Armstrong, Kathryn M., Insaidoo, Francis K., Baker, Brian M.]
通讯作者:
Baker, Brian M.
共 167 条
The quinazolinone class of antibacterial agents
-
批准号:9222697
-
项目类别:
-
资助金额:$60.2万
-
财政年份:2015
-
负责人:Mayland F Chang
-
依托单位:
The quinazolinone class of antibacterial agents
-
批准号:8856982
-
项目类别:
-
资助金额:$63.39万
-
财政年份:2015
-
负责人:Mayland F Chang
-
依托单位:
The quinazolinone class of antibacterial agents
-
批准号:9037579
-
项目类别:
-
资助金额:$60.2万
-
财政年份:2015
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8692635
-
项目类别:
-
资助金额:$99.05万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8485537
-
项目类别:
-
资助金额:$94.4万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8288684
-
项目类别:
-
资助金额:$101.68万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:8105043
-
项目类别:
-
资助金额:$101.91万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria
-
批准号:7988818
-
项目类别:
-
资助金额:$106.96万
-
财政年份:2010
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:8689089
-
项目类别:
-
资助金额:$27.08万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7665470
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7900621
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:9101816
-
项目类别:
-
资助金额:$27.16万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7370934
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:8119558
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:8268162
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Chemistry-Biochemistry-Biology Training Program at Notre Dame
-
批准号:8501527
-
项目类别:
-
资助金额:$26.79万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
Intervention of Disease by Selective Gelatinase Inhibitors
-
批准号:7494485
-
项目类别:
-
资助金额:$37.22万
-
财政年份:2007
-
负责人:Mayland F Chang
-
依托单位:
STRUCTURE ELUCIDATION OF OLIGOSACHARIDES BY FAB-MS
-
批准号:3042854
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1988
-
负责人:Mayland F Chang
-
依托单位:
STRUCTURE ELUCIDATION OF OLIGOSACHARIDES BY FAB-MS
-
批准号:3042855
-
项目类别:
-
资助金额:$0.83万
-
财政年份:1988
-
负责人:Mayland F Chang
-
依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
-
批准号:31024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:贺萍
-
依托单位: